Abstract:Cholesterol, oxysterols, and UFAs regulate the SREBP pathway through their binding to Scap (cholesterol), Insigs (oxysterols), and Ubxd8 (UFAs). These binding events influence the ER-to-Golgi trafficking of Scap–SREBP complexes and thereby modulate the proteolytic activation of SREBPs. Insulin modulates the SREBP pathway through transcriptional and post-transcriptional mechanisms that emerge from the mTOR pathway. Modulation of the SREBP pathway contributes to innate immunity and development of cancer. Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-bound transcription factors that activate genes encoding enzymes required for synthesis of cholesterol and unsaturated fatty acids. SREBPs are controlled by multiple mechanisms at the level of mRNA synthesis, proteolytic activation, and transcriptional activity. In this review, we summarize the recent findings that contribute to the current understanding of the regulation of SREBPs and their physiologic roles in maintenance of lipid homeostasis, insulin signaling, innate immunity, and cancer development. Sterol regulatory element-binding proteins (SREBPs) are a family of membrane-bound transcription factors that activate genes encoding enzymes required for synthesis of cholesterol and unsaturated fatty acids. SREBPs are controlled by multiple mechanisms at the level of mRNA synthesis, proteolytic activation, and transcriptional activity. In this review, we summarize the recent findings that contribute to the current understanding of the regulation of SREBPs and their physiologic roles in maintenance of lipid homeostasis, insulin signaling, innate immunity, and cancer development.

SREBP inhibitors: an updated patent review for 2008-present

Sterol regulatory element binding proteins and lipid metabolism

SREBP： a Novel Therapeutic Target

Anhydroicaritin Improves Diet-Induced Obesity and Hyperlipidemia and Alleviates Insulin Resistance by Suppressing SREBPs Activation

Farnesoid X receptor modulators 2014-present: a patent review

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies

Recent Advances in Research on Natural Product Inhibitors of SREBPs

[Sterol Regulatory Element Binding Protein 1 and Its Target Gene Networks].

Sterol regulatory element binding protein and nonalcoholic fatty liver disease

Insights into Sterol Regulatory Element Binding Protein in Atherosclerosis

SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond

The roles and mechanisms of SREBP1 in cancer development and drug response

SREBPs as the potential target for solving the polypharmacy dilemma

Early investigational drugs targeting PPAR-α for the treatment of metabolic disease.

SCAP/SREBPs Are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy.

Targeting SREBP-1-Mediated Lipogenesis As Potential Strategies for Cancer

Regulation and targeting of SREBP-1 in hepatocellular carcinoma

Regulation of Cholesterol and Fatty Acid Synthesis

Regulation of SREBPs and its research progress in the development of nonalcoholic fatty liver

Advanced Research of SREBP-1c Transcriptional Regulation in Fatty Liver Formation

An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 - 2013)